Anne Wojcicki, co-founder and CEO of 23andMe, talks about how ethical concerns over genetic research sometimes stem from science fiction. She uses the example of recent breakthroughs in gene editing, and how, despite existing knowledge about genetic disorders, we still can’t use innovations like “CRISPR” to cure them. That, Wojcicki says, fuels her passion to completely understand the human genome.
Related
Elise Densborn,
Splendid Spoon
From Customer to Co-CEO [Entire Talk]
Passion for a brand or industry can be an incredible starting point for gaining entrepreneurial experience.
Elise Densborn,
Splendid Spoon
From Customer to Co-CEO [Entire Talk]
Passion for a brand or industry can be an incredible starting point for gaining entrepreneurial experience.
Dante Disparte,
Circle
Ethical Crypto Innovation [Entire Talk]
To build a better crypto industry, start with ethics.
Dante Disparte,
Circle
Ethical Crypto Innovation [Entire Talk]
To build a better crypto industry, start with ethics.
Ursheet Parikh,
Mayfield
Trevor Martin,
Mammoth Biosciences
Building Biotech to Last [Entire Talk]
The keys to future success must be established at the beginning of a platform biotech company.
Ursheet Parikh,
Mayfield
Trevor Martin,
Mammoth Biosciences
Building Biotech to Last [Entire Talk]
The keys to future success must be established at the beginning of a platform biotech company.
